Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in Capital
Accumulated Deficit
Treasury Stock
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023   1,804,502        
Beginning balance at Dec. 31, 2023 $ 49,383 $ 1 $ 118,711 $ (5,029) $ (64,000) $ (300)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares and treasury shares for cash, net of offering cost (in shares)   582,900        
Issuance of common shares and treasury shares for cash, net of offering cost 7,594   7,594      
Issuance of treasury shares as collateral for a loan (in shares)   600,000        
Unrealized gain on marketable debt securities 102         102
Stock-based compensation 3,638   3,638      
Net loss $ (53,364)     (53,364)    
Ending balance (in shares) at Dec. 31, 2024 2,987,402 2,987,402        
Ending balance at Dec. 31, 2024 $ 7,353 $ 1 129,943 (58,393) (64,000) (198)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares and treasury shares for cash, net of offering cost (in shares)   1,131,500        
Issuance of common shares and treasury shares for cash, net of offering cost 3,558   (10,799)   14,357  
Stock-based compensation 1,893   1,893      
Issuance of common stock as commitment fee for future financing (in shares)   35,218        
Issuance of warrants in conjunction with debt issuance 1,260   1,260      
Issuance of common stock to convert outstanding convertible notes and interest (in shares)   3,394,196        
Issuance of common stock to convert outstanding convertible notes and interest $ 3,612 $ 2 3,610      
Issuance of common shares as collateral for a loan (in shares) 1,360,000 1,360,000        
Issuance of common shares as collateral for a loan $ 0 $ 1 (1)      
Reclassification of liability classified warrants to equity 575   575      
Shares true-up as a result of reverse stock split (in shares)   58,089        
Net loss $ (14,743)     (14,743)    
Ending balance (in shares) at Dec. 31, 2025 8,966,406 8,966,405        
Ending balance at Dec. 31, 2025 $ 3,508 $ 4 $ 126,481 $ (73,136) $ (49,643) $ (198)